Dysregulation of apoptosis genes in hematopoietic malignancies. - Wikidata - awgldk - TriplyDB

Dysregulation of apoptosis genes in hematopoietic malignancies.

Dysregulation of apoptosis genes in hematopoietic malignancies.

http://www.wikidata.org/entity/Q34658574

about

Treatment Strategies that Enhance the Efficacy and Selectivity of Mitochondria-Targeted Anticancer Agents Targeting the apoptosis pathway in hematologic malignancies Label-free recognition of drug resistance via impedimetric screening of breast cancer cells Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma Triterpenoids display single agent anti-tumor activity in a transgenic mouse model of chronic lymphocytic leukemia and small B cell lymphoma.Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies Cellular stress responses: cell survival and cell death Computational identification of transcriptional regulators in human endotoxemia Prognostic impact of bim, puma, and noxa expression in human colon carcinomas.Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma.BCL2A1a over-expression in murine hematopoietic stem and progenitor cells decreases apoptosis and results in hematopoietic transformation.Abnormal expression of Pygopus 2 correlates with a malignant phenotype in human lung cancer.PQJS380: a novel lead compound to induce apoptosis in acute lymphoblastic leukemia cells Ardipusilloside I induces apoptosis by regulating Bcl-2 family proteins in human mucoepidermoid carcinoma Mc3 cells.Caspase-mediated cell death in hematological malignancies: theoretical considerations, methods of assessment, and clinical implications.Induction of cancer cell death by isoflavone: the role of multiple signaling pathways.Acute promyelocytic leukemia: PML/RARalpha and the leukemic stem cell.Combination of taxol and Bcl-2 siRNA induces apoptosis in human glioblastoma cells and inhibits invasion, angiogenesis and tumour growth.Mechanisms of PECAM-1-mediated cytoprotection and implications for cancer cell survival.Bcl-2 overexpression enhances tumor-specific T-cell survival Metabolism pathways in chronic lymphocytic leukemia.An evidence-based review of obatoclax mesylate in the treatment of hematological malignancies At High Levels, Constitutively Activated STAT3 Induces Apoptosis of Chronic Lymphocytic Leukemia Cells.TNF receptor-associated factor (TRAF) domain and Bcl-2 cooperate to induce small B cell lymphoma/chronic lymphocytic leukemia in transgenic mice Mitochondria in cancer: at the crossroads of life and death Obatoclax as a perpetrator in drug-drug interactions and its efficacy in multidrug resistance cell lines.Overexpression of Hiwi Inhibits the Cell Growth of Chronic Myeloid Leukemia K562 Cells and Enhances Their Chemosensitivity to Daunomycin.Overexpression of Hiwi Inhibits the Growth and Migration of Chronic Myeloid Leukemia Cells.The BH3-only protein Puma plays an essential role in p53-mediated apoptosis of chronic lymphocytic leukemia cells.Regulation of cell death in cancer-possible implications for immunotherapy.Combined treatment with EGFR inhibitors and arsenite upregulated apoptosis in human EGFR-positive melanomas: a role of suppression of the PI3K-AKT pathway.The Bax BH3 peptide H2-H3 promotes apoptosis by inhibiting Bcl-2's pore-forming and anti-Bax activities in the membrane.Safety, efficacy, and pharmacokinetics of navitoclax (ABT-263) in combination with erlotinib in patients with advanced solid tumors.Expression of Bcl-2 and Bcl-xL in cutaneous and bone marrow lesions of mastocytosis.Targeting apoptosis signaling pathways for anticancer therapy Hydrogen peroxide is critical for UV-induced apoptosis inhibition.Selective IAP inhibition results in sensitization of unstimulated but not CD40-stimulated chronic lymphocytic leukaemia cells to TRAIL-induced apoptosis.Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.Expression of TNF-receptor associated factor 2 correlates with poor progression-free survival time in ABC-like primary nodal diffuse large B-cell lymphomas.Neurotensin receptor type 2 protects B-cell chronic lymphocytic leukemia cells from apoptosis.

P2860

Q26800890-BE51790F-F1FB-4D51-85F5-3243DFB72264 Q27024422-212FEC31-951E-44BB-AF6E-DDB37998179E Q28487553-5EADEC7A-6F28-4EF2-AAD5-B4C27A07D129 Q29615607-FF503460-14ED-4B53-90E3-398DEC32BF71 Q33288957-C47F65F3-F2B6-4E2A-A61A-1A2979E0148A Q33422543-47461982-2086-454E-8999-06B8B1B86AA7 Q33674213-AA2AFD90-BB39-44B5-BBF1-492248A11487 Q33921020-14D7166D-2781-498D-94B9-F90F2C3FB6C1 Q34167987-62FA9C06-1E5E-4A1A-B9CC-A14141D4E659 Q34292891-532C7ADE-69DB-4BC2-8D29-62203725DF1C Q34464894-DD874EC6-A8E7-4A25-9287-EDDFA7F79207 Q34832587-2B299B6B-7A5C-4AF2-A16D-F23468250415 Q35047163-2D5E8A8A-515F-4B8C-8821-C7D5EBD5ECBC Q35047698-320CC0AD-62E9-4475-A466-9FB09FBBE316 Q35198905-B87E46D2-F425-4B95-A390-AFB63FF7E695 Q35628160-B7E69EDD-6FAE-4052-B9F4-6AE7DA179F03 Q35753735-C8C090F6-134C-4F51-BBF5-B95891B53C87 Q35832038-E2BFB1B3-8CD7-4604-8043-C65696262168 Q36272597-E377F448-8855-4E09-AF5C-1EE62D8E7999 Q36327125-58E32E30-2A6A-4195-9830-FEA2540F0660 Q36693111-8B0B1748-D5E0-44E4-A684-2C74F3E633B5 Q36696524-B1458B32-347D-4855-A25B-80DC8C22D7D3 Q36906043-1876582B-2881-4182-BBB7-CF47C579C7AB Q37692413-900C15E2-FBDB-4106-8316-B418A62D36F5 Q37908235-1F739CCC-1664-41EF-98E6-1B0F1EBB295A Q38845179-7AE39F0D-609A-4106-8EC3-366588B9FECC Q38907442-5A95EC01-5026-4454-910D-7456E3D34D8C Q38907622-28D2A64A-7EA1-4CE3-BF96-0E32BFC1F5AC Q39177637-5635119B-857A-4BBE-812E-59DCCBF248B7 Q39461469-BC9A45A5-7F09-4513-BCC7-97B7219DA361 Q39559565-86C57ACA-76E3-48A6-B0AF-03D9EAF9C9CC Q39780082-BFB5B614-ED38-48E7-8C77-FC1C068241E2 Q40485092-59D572B7-2F79-4784-980A-486B7065C5CE Q41812863-D5B6A42F-9436-44DD-A15E-303A7FABD095 Q42175008-F994D6C3-B814-4504-8A5E-F12156B8228D Q42802249-0C172536-3256-4AC0-9F62-0A4772C76F67 Q42930877-A16F26E9-06F3-4211-A50F-7F0FD90EF220 Q43670982-67CABB9D-74B2-4678-8BD6-4862EB168C48 Q46724259-620362F3-59DE-4E58-A1A1-F1DA8BF48EE4 Q47616548-4BD4085F-4AF0-415A-9F01-C73D6822E744

P2860

Dysregulation of apoptosis genes in hematopoietic malignancies.

http://www.wikidata.org/entity/Q34658574

description

2002 nî lūn-bûn

@nan

2002 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Dysregulation of apoptosis genes in hematopoietic malignancies.

@ast

Dysregulation of apoptosis genes in hematopoietic malignancies.

@en

Dysregulation of apoptosis genes in hematopoietic malignancies.

@nl

type

label

Dysregulation of apoptosis genes in hematopoietic malignancies.

@ast

Dysregulation of apoptosis genes in hematopoietic malignancies.

@en

Dysregulation of apoptosis genes in hematopoietic malignancies.

@nl

prefLabel

Dysregulation of apoptosis genes in hematopoietic malignancies.

@ast

Dysregulation of apoptosis genes in hematopoietic malignancies.

@en

Dysregulation of apoptosis genes in hematopoietic malignancies.

@nl

P1433

Q34658574-C239762E-4063-4799-B6F3-9618E89CE990

P1476

Q34658574-A2999700-C104-4809-934D-0C79E6369B2B

P2093

Q34658574-3746D8F7-1A31-41FD-9B7F-377BDCC0349A

Q34658574-88D3D3D4-782A-40BF-9B77-BEAE518531DB

Q34658574-AD64E453-9A55-4E09-A63C-4B011CF9F03B

P2860

Q34658574-1C3E36AB-E40B-4DDD-AA9D-008AC2E5C5DA

Q34658574-392C38DB-E5AB-45CF-80F2-0DDDBB38F3E6

Q34658574-6D100F0A-FCC9-4559-A53C-EFD7FCB17D92

Q34658574-870E92E8-3677-431B-91A2-5D03C47DBA53

Q34658574-F97C4CF7-A768-42AA-8789-08FFBA46E8F4

P2888

Q34658574-43FF0413-A511-468E-A339-DADCA7595680

P304

Q34658574-4E422FD1-6D6C-4224-BD78-921F2A9A8E6E

P31

Q34658574-380E50B3-6B0B-48F6-AB74-C733B092AB1B

P356

Q34658574-7D6A16A4-1F62-4CBD-8B23-3BF03A04F64E

P407

Q34658574-5776C5B2-50EA-4B24-967E-34023C6B8CB6

P433

Q34658574-6814D2A8-2E35-41F0-B2BE-37F431F70BF0

P478

Q34658574-2251EB1B-7C91-4330-916F-1E53A1114E46

P50

Q34658574-6C56A46C-6070-4010-A3E1-0D24C373C32B

P577

Q34658574-1B4F4E50-C508-487A-9B4E-1B86469C1230

P5875

Q34658574-DE989C66-42D6-4D49-8220-3B261453F278

P6179

Q34658574-1FA840BD-2D57-4C62-88F1-691DE03CBE79

P698

Q34658574-4E0025B8-F3B3-4247-95AB-7C9EB25403DC

P356

P1433

P1476

Dysregulation of apoptosis genes in hematopoietic malignancies

@en

P2093

Irene M Pedersen

http://www.w3.org/2001/XMLSchema#string

John C Reed

http://www.w3.org/2001/XMLSchema#string

Shinichi Kitada

http://www.w3.org/2001/XMLSchema#string

P2860

BCL-2 family members and the mitochondria in apoptosis

Dysregulation of apoptosis in cancer.

Apoptosis and cancer chemotherapy.

Hormonal regulation of physiological cell turnover and apoptosis.

BCL10 is rarely mutated in human prostate carcinoma, small-cell lung cancer, head and neck tumours, renal carcinoma and sarcomas. MPT Collaborators, St George's Hospital Collaborators.

P2888

P304

3459-3474

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.ONC.1205327

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11339328

http://www.w3.org/2001/XMLSchema#string

P6179

1012342332

http://www.w3.org/2001/XMLSchema#string

P698

12032782

http://www.w3.org/2001/XMLSchema#string